Effects of ON-Hours Versus OFF-Hours Admission on Outcome in Patients With Myocardial Infarction and Cardiogenic Shock: Results From the CULPRIT-SHOCK Trial

Myocardial Infarction

Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction

J Am Coll Cardiol.

Levy B, Clere-Jehl R, Legras A, Morichau-Beauchant T, Leone M, Frederique G, Quenot JP, Kimmoun A, Cariou A, Lassus J, Harjola VP, Meziani F, Louis G, Rossignol P, Duarte K, Girerd N, Mebazaa A, Vignon P, Collaborators

doi: 10.1016/j.jacc.2018.04.051.

Myocardial InfarctionTherapy and Intervention

Radial versus femoral artery access for percutaneous coronary artery intervention in patients with acute myocardial infarction and multivessel disease complicated by cardiogenic shock: Subanalysis from the CULPRIT-SHOCK trial

Am Heart J.

Guedeney P, Thiele H, Kerneis M, Barthélémy O, Baumann S, Sandri M, de Waha-Thiele S, Fuernau G, Rouanet S, Piek JJ, Landmesser U, Hauguel-Moreau M, Zeitouni M, Silvain J, Lattuca B, Windecker S, Collet JP, Desch S, Zeymer U, Montalescot G, Akin I, CULPRIT-SHOCK Investigators.

doi: 10.1016/j.ahj.2020.04.014.

Myocardial Infarction

PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock

N Engl J Med.

Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R, Nordbeck P, Geisler T, Landmesser U, Skurk C, Fach A, Lapp H, Piek JJ, Noc M, Goslar T, Felix SB, Maier LS, Stepinska J, Oldroyd K, Serpytis P, Montalescot G, Barthelemy O, Huber K, Windecker S, Savonitto S, Torremante P, Vrints C, Schneider S, Desch S, Zeymer U; CULPRIT-SHOCK Investigators

doi: 10.1056/NEJMoa1710261.

Cardiac Arrest or DeathMyocardial Infarction

Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction

Circulation.

Fuernau G, Beck J, Desch S, Eitel I, Jung C, Erbs S, Mangner N, Lurz P, Fengler K, Jobs A, Vonthein R, de Waha-Thiele S, Sandri M, Schuler G, Thiele H

doi: 10.1161/CIRCULATIONAHA.117.032722.

Cardiac Arrest or DeathMyocardial Infarction

Revascularization Practices and Outcomes in Patients With Multivessel Coronary Artery Disease Who Presented With Acute Myocardial Infarction and Cardiogenic Shock in the US, 2009-2018

JAMA Intern Med.

Khera R, Secemsky EA, Wang Y, Desai NR, Krumholz HM, Maddox TM, Shunk KA, Virani SS, Bhatt DL, Curtis J, Yeh RW

doi: 10.1001/jamainternmed.

Heart, Artery and Coronary Diseases

Impact of Chronic Total Occlusion and Revascularization Strategy in Patients with Infarct-Related Cardiogenic Shock A Subanalysis of the CULPRIT-SHOCK trial

Am Heart J

Braik N, Guedeney P, Behnes M, Desch S, Barthélémy O, Sandri M, de Waha-Thiele S, Fuernau G, Rouanet S, Hauguel-Moreau M, Zeitouni M, Overtchouk P, Ouarrak T, Schneider S, Zeymer U, Thiele H, Montalescot G, Akin I

doi: 10.1016/j.ahj.2020.11.009

Cardiac Arrest or DeathTherapy and Intervention

Association of Culprit Lesion Location With Outcomes of Culprit-Lesion-Only vs Immediate Multivessel Percutaneous Coronary Intervention in Cardiogenic Shock: A Post Hoc Analysis of a Randomized Clinical Trial

JAMA Cardiol.

Farhan S, Vogel B, Montalescot G, Barthelemy O, Zeymer U, Desch S, de Waha-Thiele S, Maier LS, Sandri M, Akin I, Fuernau G, Ouarrak T, Hauguel-Moreau M, Schneider S, Thiele H, Huber K

doi: 10.1001/jamacardio.

Myocardial Infarction

Biomarkers predictive of late cardiogenic shock development in patients with suspected ST-elevation myocardial infarction

Eur Heart J Acute Cardiovasc Care.

Frydland M, Møller JE, Lindholm MG, Hansen R, Wiberg S, Lerche Helgestad OK, Thomsen JH, Goetze JP, Engstrøm T, Frikke-Schmidt R, Ravn HB, Holmvang L, Jensen LO, Kjaergaard J, Hassager C

doi: 10.1177/2048872619896063.

Myocardial InfarctionTherapy and Intervention

Impact of microaxillar mechanical left ventricular support on renal resistive index in patients with cardiogenic shock after myocardial infarction: a pilot trial to predict renal organ dysfunction in cardiogenic shock

Eur Heart J Acute Cardiovasc Care.

Markus B, Patsalis N, Chatzis G, Luesebrink U, Ahrens H, Schieffer B, Karatolios K

doi: 10.1177/2048872619860218.

Related content

Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction

Radial versus femoral artery access for percutaneous coronary artery intervention in patients with acute myocardial infarction and multivessel disease complicated by cardiogenic shock: Subanalysis from the CULPRIT-SHOCK trial

PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock

Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction

Revascularization Practices and Outcomes in Patients With Multivessel Coronary Artery Disease Who Presented With Acute Myocardial Infarction and Cardiogenic Shock in the US, 2009-2018

Impact of Chronic Total Occlusion and Revascularization Strategy in Patients with Infarct-Related Cardiogenic Shock A Subanalysis of the CULPRIT-SHOCK trial

Association of Culprit Lesion Location With Outcomes of Culprit-Lesion-Only vs Immediate Multivessel Percutaneous Coronary Intervention in Cardiogenic Shock: A Post Hoc Analysis of a Randomized Clinical Trial

Biomarkers predictive of late cardiogenic shock development in patients with suspected ST-elevation myocardial infarction

Impact of microaxillar mechanical left ventricular support on renal resistive index in patients with cardiogenic shock after myocardial infarction: a pilot trial to predict renal organ dysfunction in cardiogenic shock